Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1
- 1 September 1997
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 16 (9), 660-668
- https://doi.org/10.1007/bf01708556
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentinAIDS, 1996
- Clinical Significance of Drug Resistance in Human Immunodeficiency VirusClinical Infectious Diseases, 1995
- Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine TreatmentThe Journal of Infectious Diseases, 1995
- Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT TrialAIDS, 1993
- Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive SubjectsThe Journal of Infectious Diseases, 1992
- HIV-1 sensitivity to zidovudine and clinical outcome in childrenThe Lancet, 1992
- Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytesAIDS, 1991
- Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyThe Lancet, 1990
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987